1h Free Analyst Time
Breast cancer remains one of the leading causes of cancer-related mortality among women globally, driving relentless innovation in screening technologies. Early detection significantly improves survival rates, prompting healthcare providers to adopt advanced imaging modalities and minimally invasive biopsy techniques. As patient awareness grows and regulatory frameworks evolve, demand for precision-oriented screening devices intensifies. Clinical stakeholders now prioritize high diagnostic accuracy, reduced patient discomfort, and streamlined workflows, while payers seek cost-effective solutions that demonstrate clear outcomes.Speak directly to the analyst to clarify any post sales queries you may have.
In response, manufacturers are investing heavily in research and development to integrate artificial intelligence, enhance image resolution, and expand portable screening platforms. Regulatory approvals across major markets have accelerated market entry for next-generation modalities such as tomosynthesis and digital breast MRI. Meanwhile, reimbursement policies are adapting to cover emerging services, further stimulating uptake. This executive summary sets the stage for a comprehensive analysis of transformative trends, trade policy impacts, segmentation dynamics, regional growth drivers, competitive positioning, and strategic recommendations tailored for industry leaders operating in this dynamic landscape.
Transformative Shifts Reimagining Screening Technologies
The screening device landscape is undergoing transformative shifts fueled by technological breakthroughs and changing care delivery models. Artificial intelligence integration is redefining diagnostic workflows, enabling automated lesion detection, enhanced radiologist support, and predictive risk stratification. Personalized screening protocols are gaining traction, with age- and risk-adjusted strategies optimizing resource allocation and patient outcomes.Portable and point-of-care devices are expanding access in rural and underserved regions, while telehealth consultations facilitate remote interpretation and patient education. Advanced imaging modalities-such as digital tomosynthesis and contrast-enhanced breast MRI-deliver superior tissue differentiation, reducing false positives and biopsy rates. Concurrently, emerging reimbursement models reward value-based care, incentivizing providers to invest in high-efficiency systems that demonstrate shortened exam times and improved throughput.
Supply chain resilience has become paramount in light of recent disruptions, prompting partnerships with local contract manufacturers and vertical integration strategies. Collectively, these shifts are reshaping competitive dynamics, with innovators that combine technological sophistication, data analytics, and patient-centric design poised to capture market leadership.
Assessing the Cumulative Impact of U.S. Tariffs in 2025
The imposition of new United States tariffs effective in 2025 has introduced significant cost pressures across the screening device value chain. Components sourced internationally-particularly high-precision imaging sensors, specialized detectors, and advanced materials-face increased import duties, prompting device manufacturers to reassess sourcing strategies. These tariffs have elevated production costs by up to 8-10% for some segments, compelling tier-one suppliers to explore alternative procurement from domestic vendors or nearshore partners.In reaction to these levies, many original equipment manufacturers have initiated dual-sourcing agreements and invested in local manufacturing facilities to mitigate duty exposure. While these adjustments entail upfront capital expenditure, they reduce long-term volatility and strengthen supply continuity. At the same time, some providers have strategically absorbed tariff-related cost increases to maintain competitive pricing, leveraging operational efficiencies and scale economies to preserve margins.
Healthcare providers, confronted with potential price hikes, are renegotiating service contracts and demanding greater transparency around equipment lifecycle costs. In parallel, insurers and government payers are reviewing reimbursement schedules to reflect the evolving cost base. Ultimately, the 2025 tariffs have accelerated the industry’s shift toward supply chain diversification, on-shore production capacity, and collaborative partnerships focused on shared risk and innovation.
Key Segmentation Insights Driving Market Dynamics
A nuanced understanding of market segmentation reveals critical growth vectors and investment priorities. When viewed through the lens of product type, opportunities cluster around mammography and breast ultrasound as established modalities, while breast biopsy technologies-subdivided into market-driven consumables and research-oriented platforms-are emerging rapidly. Computed tomography and digital radiography represent the core of breast imaging devices, with diagnostic and screening MRI systems enabling deeper tissue characterization. Automation features in computer-aided detection solutions are bifurcated between efficiency-focused workflows and advanced radiologist support tools.From a technology standpoint, three-dimensional breast imaging and tomosynthesis are at the forefront of adoption, underpinned by analog-to-digital transitions and advanced Doppler-based analytics facilitated by stereotactic arrays. End-user applications span academic and research institutes conducting clinical trials and innovative R&D, clinics focused on diagnostic accuracy and patient outreach, and hospitals prioritizing cost efficiency, safety, and rapid service delivery.
Screening methods differentiate between high-risk cohorts requiring specialized imaging protocols and routine programs for the general population. Age-based cohorts range from patients below 40 to those aged 65 and above, with continuous monitoring and early diagnosis applications addressing the latter group’s unique needs. Patient demographics bifurcate the market into men's and women’s screening pathways, reflecting tailored clinical guidelines. Distribution channels encompass direct sales models, traditional distributors, and telehealth services such as online advice platforms and remote consultations. Finally, innovative feature sets-encompassing artificial intelligence integration, automated analysis suites, and connectivity via digital interfaces and remote data access-define the cutting edge of device capabilities.
Key Regional Insights Shaping Growth Trajectories
Regional dynamics underscore divergent adoption patterns and growth catalysts. In the Americas, established reimbursement frameworks and high healthcare expenditure maintain robust demand for advanced screening systems, particularly in digital mammography and AI-enabled solutions. The region’s mature payer landscape supports rapid integration of new technologies, while rural telehealth initiatives are expanding access to underserved communities.Across Europe, the Middle East, and Africa, heterogeneous regulatory environments and varying public health budgets shape adoption rates. Western European nations lead in tomosynthesis deployment and MRI screening programs, whereas emerging markets in Eastern Europe and the Middle East prioritize cost-effective ultrasound and portable imaging units. Africa’s screening market remains nascent but is benefiting from donor-funded initiatives and public-private partnerships aimed at scaling early detection services.
The Asia-Pacific region exhibits the fastest compound annual growth, driven by government-led awareness campaigns, increasing disposable incomes, and expanding healthcare infrastructure in China, India, and Southeast Asia. Governments are mandating population-based screening registries, while private hospitals invest heavily in state-of-the-art imaging suites. However, fragmented healthcare systems and reimbursement inconsistencies pose challenges to standardized technology adoption.
Key Companies Insights on Competitive Positioning
Competitive dynamics are anchored by a diverse ecosystem of incumbents and challengers. Legacy instrumentation providers such as General Electric, Siemens Healthineers, Philips Healthcare, Canon Medical Systems, Fujifilm Holdings, and Toshiba Medical have reinforced their portfolios through strategic acquisitions and R&D investments, cementing leadership in core imaging modalities.Innovative specialists like Hologic, iCAD, and QView Medical are driving algorithm-centric solutions, while software pioneers such as ScreenPoint Medical and CureMetrix excel in deep learning-based detection tools. Agilent Technologies and Thermo Fisher Scientific underpin research workflows with high-precision laboratory platforms. Emerging disruptors-Endomag with its magnetic localization technology and Volpara Health Technologies for volumetric breast density assessment-are carving niche positions by addressing specific clinical pain points.
Collaborations between device manufacturers and digital health firms are accelerating feature integration, with direct sales channels, distributor networks, and telehealth partnerships broadening market reach. Companies offering interoperable connectivity solutions are gaining favor, as providers gravitate toward unified data ecosystems that support remote monitoring and longitudinal patient management.
Actionable Recommendations for Industry Leaders
Industry leaders must pursue a multi-pronged strategy to sustain growth and competitive advantage. First, accelerating artificial intelligence integration across screening platforms will enhance diagnostic accuracy and operational efficiency. Investing in advanced analytics capabilities, including predictive modeling and real-time decision support, will position organizations at the forefront of value-based care.Second, diversifying supply chains through nearshoring and strategic partnerships with contract manufacturers will mitigate tariff impacts and ensure component availability. Establishing regional production hubs can also unlock cost efficiencies and reduce time-to-market for new device iterations.
Third, aligning product development with evolving reimbursement frameworks is critical. Engaging payers early to demonstrate clinical efficacy and cost-effectiveness will facilitate favorable coverage policies. Simultaneously, designing flexible pricing models-such as outcome-based leasing or subscription services-can broaden adoption among resource-constrained healthcare systems.
Fourth, expanding into emerging demographic and geographic segments requires tailored solutions. Portable imaging units and telehealth services should be optimized for low-resource settings, while personalized screening protocols must address diverse risk profiles across age groups and genders.
Finally, forging collaborative ecosystems that integrate devices, software, and connectivity will deliver end-to-end value propositions. Partnerships with digital health firms, academic institutions, and patient advocacy groups can drive continuous innovation, enhance patient engagement, and reinforce market leadership.
Conclusion: Charting the Future of Screening Excellence
The current landscape presents a compelling opportunity to redefine breast cancer screening paradigms. Through rigorous segmentation analysis, we’ve identified high-growth cohorts, from advanced tomosynthesis adopters to telehealth-enabled diagnostic pathways. Regional insights highlight pockets of unmet need and reimbursement catalysts that can be leveraged for accelerated expansion. Competitive profiling underscores the importance of marrying hardware excellence with software intelligence and connectivity.By adopting the recommended strategies-AI integration, supply chain diversification, reimbursement alignment, targeted market expansion, and ecosystem partnerships-organizations can achieve sustainable differentiation. Success will depend on proactive stakeholder engagement, data-driven innovation roadmaps, and agile operational frameworks that adapt to evolving clinical guidelines and policy shifts. The path forward demands strategic clarity, disciplined execution, and unwavering commitment to improving patient outcomes.
Market Segmentation & Coverage
This research report categorizes the Breast Cancer Screening Device Market to forecast the revenues and analyze trends in each of the following sub-segmentations:
- Breast Biopsy
- Market
- Research
- Breast Imaging Devices
- Computed Tomography
- Digital Radiography
- Breast Mri
- Mri (Magnetic Resonance Imaging)
- Diagnostic Mri
- Screening Mri
- Mri (Magnetic Resonance Imaging)
- Breast Ultrasound
- Computer-Aided Detection
- Automation
- Radiologist Support
- Mammography
- 3D Breast Imaging
- Analog Technology
- Digital Technology
- Advanced Technologies
- Doppler Analysis
- Stereotactic Arrays
- Advanced Technologies
- Tomosynthesis
- Academic And Research Institutes
- Clinical Trials
- Innovative Solutions
- Research And Development
- Clinics
- Clinical Outils
- Diagnostic Accuracy
- Patient Outreach
- Hospitals
- Cost Efficiency
- Patient Safety
- Service Speed
- High-Risk Screening
- Routine Screening Programs
- 40-49
- 50-64
- 65 And Above
- Continuous Monitoring
- Early Diagnosis
- Below 40
- Men
- Women
- Direct Sales
- Distributors
- Telehealth
- Online Advice Services
- Telemedicine Consultations
- Artificial Intelligence Integration
- Automated Analysis Tools
- Connectivity
- Digital Interfaces
- Remote Data Access
This research report categorizes the Breast Cancer Screening Device Market to forecast the revenues and analyze trends in each of the following sub-regions:
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
This research report categorizes the Breast Cancer Screening Device Market to delves into recent significant developments and analyze trends in each of the following companies:
- Agilent Technologies, Inc.
- Canon Medical Systems Corporation
- CureMetrix
- Endomag
- FUJIFILM Holdings Corporation
- GE HealthCare
- Hologic, Inc.
- iCAD, Inc.
- Konica Minolta, Inc.
- Philips Healthcare
- Planmed Oy
- QView Medical, Inc.
- ScreenPoint Medical
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
- Toshiba Medical Systems Corporation
- Volpara Health Technologies
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Breast Cancer Screening Device Market, by Product Type
8.1. Introduction
8.2. Breast Biopsy
8.2.1. Market
8.2.2. Research
8.3. Breast Imaging Devices
8.3.1. Computed Tomography
8.3.2. Digital Radiography
8.4. Breast Mri
8.4.1. Mri (Magnetic Resonance Imaging)
8.4.1.1. Diagnostic Mri
8.4.1.2. Screening Mri
8.5. Breast Ultrasound
8.6. Computer-Aided Detection
8.6.1. Automation
8.6.2. Radiologist Support
8.7. Mammography
9. Breast Cancer Screening Device Market, by Technology
9.1. Introduction
9.2. 3D Breast Imaging
9.3. Analog Technology
9.4. Digital Technology
9.4.1. Advanced Technologies
9.4.1.1. Doppler Analysis
9.4.1.2. Stereotactic Arrays
9.5. Tomosynthesis
10. Breast Cancer Screening Device Market, by End-User Application
10.1. Introduction
10.2. Academic And Research Institutes
10.2.1. Clinical Trials
10.2.2. Innovative Solutions
10.2.3. Research And Development
10.3. Clinics
10.3.1. Clinical Outils
10.3.2. Diagnostic Accuracy
10.3.3. Patient Outreach
10.4. Hospitals
10.4.1. Cost Efficiency
10.4.2. Patient Safety
10.4.3. Service Speed
11. Breast Cancer Screening Device Market, by Screening Methods
11.1. Introduction
11.2. High-Risk Screening
11.3. Routine Screening Programs
12. Breast Cancer Screening Device Market, by Age Group
12.1. Introduction
12.2. 40-49
12.3. 50-64
12.4. 65 And Above
12.4.1. Continuous Monitoring
12.4.2. Early Diagnosis
12.5. Below 40
13. Breast Cancer Screening Device Market, by Patient Demographics
13.1. Introduction
13.2. Men
13.3. Women
14. Breast Cancer Screening Device Market, by Distribution Channel
14.1. Introduction
14.2. Direct Sales
14.3. Distributors
14.4. Telehealth
14.4.1. Online Advice Services
14.4.2. Telemedicine Consultations
15. Breast Cancer Screening Device Market, by Innovative Features
15.1. Introduction
15.2. Artificial Intelligence Integration
15.3. Automated Analysis Tools
15.4. Connectivity
15.4.1. Digital Interfaces
15.4.2. Remote Data Access
16. Americas Breast Cancer Screening Device Market
16.1. Introduction
16.2. Argentina
16.3. Brazil
16.4. Canada
16.5. Mexico
16.6. United States
17. Asia-Pacific Breast Cancer Screening Device Market
17.1. Introduction
17.2. Australia
17.3. China
17.4. India
17.5. Indonesia
17.6. Japan
17.7. Malaysia
17.8. Philippines
17.9. Singapore
17.10. South Korea
17.11. Taiwan
17.12. Thailand
17.13. Vietnam
18. Europe, Middle East & Africa Breast Cancer Screening Device Market
18.1. Introduction
18.2. Denmark
18.3. Egypt
18.4. Finland
18.5. France
18.6. Germany
18.7. Israel
18.8. Italy
18.9. Netherlands
18.10. Nigeria
18.11. Norway
18.12. Poland
18.13. Qatar
18.14. Russia
18.15. Saudi Arabia
18.16. South Africa
18.17. Spain
18.18. Sweden
18.19. Switzerland
18.20. Turkey
18.21. United Arab Emirates
18.22. United Kingdom
19. Competitive Landscape
19.1. Market Share Analysis, 2024
19.2. FPNV Positioning Matrix, 2024
19.3. Competitive Analysis
19.3.1. Agilent Technologies, Inc.
19.3.2. Canon Medical Systems Corporation
19.3.3. CureMetrix
19.3.4. Endomag
19.3.5. FUJIFILM Holdings Corporation
19.3.6. GE HealthCare
19.3.7. Hologic, Inc.
19.3.8. iCAD, Inc.
19.3.9. Konica Minolta, Inc.
19.3.10. Philips Healthcare
19.3.11. Planmed Oy
19.3.12. QView Medical, Inc.
19.3.13. ScreenPoint Medical
19.3.14. Siemens Healthineers AG
19.3.15. Thermo Fisher Scientific Inc.
19.3.16. Toshiba Medical Systems Corporation
19.3.17. Volpara Health Technologies
20. ResearchAI
21. ResearchStatistics
22. ResearchContacts
23. ResearchArticles
24. Appendix
List of Figures
FIGURE 1. BREAST CANCER SCREENING DEVICE MARKET MULTI-CURRENCY
FIGURE 2. BREAST CANCER SCREENING DEVICE MARKET MULTI-LANGUAGE
FIGURE 3. BREAST CANCER SCREENING DEVICE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY END-USER APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY END-USER APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY SCREENING METHODS, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY SCREENING METHODS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 20. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY INNOVATIVE FEATURES, 2024 VS 2030 (%)
FIGURE 22. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY INNOVATIVE FEATURES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. AMERICAS BREAST CANCER SCREENING DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. AMERICAS BREAST CANCER SCREENING DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. UNITED STATES BREAST CANCER SCREENING DEVICE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 26. UNITED STATES BREAST CANCER SCREENING DEVICE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC BREAST CANCER SCREENING DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC BREAST CANCER SCREENING DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. BREAST CANCER SCREENING DEVICE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 32. BREAST CANCER SCREENING DEVICE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BREAST CANCER SCREENING DEVICE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY MARKET, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST IMAGING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST MRI, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY MRI (MAGNETIC RESONANCE IMAGING), BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY DIAGNOSTIC MRI, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY SCREENING MRI, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY MRI (MAGNETIC RESONANCE IMAGING), 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST MRI, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY COMPUTER-AIDED DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY AUTOMATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY RADIOLOGIST SUPPORT, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY COMPUTER-AIDED DETECTION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY MAMMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY 3D BREAST IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY ANALOG TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY DIGITAL TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY ADVANCED TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY DOPPLER ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY STEREOTACTIC ARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY ADVANCED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY DIGITAL TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY TOMOSYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY END-USER APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY INNOVATIVE SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY CLINICAL OUTILS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY DIAGNOSTIC ACCURACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY PATIENT OUTREACH, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY COST EFFICIENCY, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY PATIENT SAFETY, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY SERVICE SPEED, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY SCREENING METHODS, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY HIGH-RISK SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY ROUTINE SCREENING PROGRAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY 40-49, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY 50-64, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY 65 AND ABOVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY CONTINUOUS MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY EARLY DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY 65 AND ABOVE, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BELOW 40, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY MEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY WOMEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY TELEHEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY ONLINE ADVICE SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY TELEMEDICINE CONSULTATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY TELEHEALTH, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY INNOVATIVE FEATURES, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY ARTIFICIAL INTELLIGENCE INTEGRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY AUTOMATED ANALYSIS TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY CONNECTIVITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY DIGITAL INTERFACES, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY REMOTE DATA ACCESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS BREAST CANCER SCREENING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST MRI, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS BREAST CANCER SCREENING DEVICE MARKET SIZE, BY MRI (MAGNETIC RESONANCE IMAGING), 2018-2030 (USD MILLION)
TABLE 86. AMERICAS BREAST CANCER SCREENING DEVICE MARKET SIZE, BY COMPUTER-AIDED DETECTION, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS BREAST CANCER SCREENING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS BREAST CANCER SCREENING DEVICE MARKET SIZE, BY DIGITAL TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS BREAST CANCER SCREENING DEVICE MARKET SIZE, BY ADVANCED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS BREAST CANCER SCREENING DEVICE MARKET SIZE, BY END-USER APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS BREAST CANCER SCREENING DEVICE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS BREAST CANCER SCREENING DEVICE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS BREAST CANCER SCREENING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS BREAST CANCER SCREENING DEVICE MARKET SIZE, BY SCREENING METHODS, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS BREAST CANCER SCREENING DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS BREAST CANCER SCREENING DEVICE MARKET SIZE, BY 65 AND ABOVE, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS BREAST CANCER SCREENING DEVICE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS BREAST CANCER SCREENING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS BREAST CANCER SCREENING DEVICE MARKET SIZE, BY TELEHEALTH, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS BREAST CANCER SCREENING DEVICE MARKET SIZE, BY INNOVATIVE FEATURES, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS BREAST CANCER SCREENING DEVICE MARKET SIZE, BY CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS BREAST CANCER SCREENING DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST MRI, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY MRI (MAGNETIC RESONANCE IMAGING), 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY COMPUTER-AIDED DETECTION, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY DIGITAL TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY ADVANCED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY END-USER APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY SCREENING METHODS, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY 65 AND ABOVE, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY TELEHEALTH, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY INNOVATIVE FEATURES, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST MRI, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY MRI (MAGNETIC RESONANCE IMAGING), 2018-2030 (USD MILLION)
TABLE 129. BRAZIL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY COMPUTER-AIDED DETECTION, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY DIGITAL TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY ADVANCED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY END-USER APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY SCREENING METHODS, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY 65 AND ABOVE, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY TELEHEALTH, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY INNOVATIVE FEATURES, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL BREAST CANCER SCREENING DEVICE MARKET SIZE, BY CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 145. CANADA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 146. CANADA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 147. CANADA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 148. CANADA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST MRI, 2018-2030 (USD MILLION)
TABLE 149. CANADA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY MRI (MAGNETIC RESONANCE IMAGING), 2018-2030 (USD MILLION)
TABLE 150. CANADA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY COMPUTER-AIDED DETECTION, 2018-2030 (USD MILLION)
TABLE 151. CANADA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 152. CANADA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY DIGITAL TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 153. CANADA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY ADVANCED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 154. CANADA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY END-USER APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. CANADA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 156. CANADA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 157. CANADA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 158. CANADA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY SCREENING METHODS, 2018-2030 (USD MILLION)
TABLE 159. CANADA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 160. CANADA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY 65 AND ABOVE, 2018-2030 (USD MILLION)
TABLE 161. CANADA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 162. CANADA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. CANADA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY TELEHEALTH, 2018-2030 (USD MILLION)
TABLE 164. CANADA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY INNOVATIVE FEATURES, 2018-2030 (USD MILLION)
TABLE 165. CANADA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 166. MEXICO BREAST CANCER SCREENING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 167. MEXICO BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 168. MEXICO BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 169. MEXICO BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST MRI, 2018-2030 (USD MILLION)
TABLE 170. MEXICO BREAST CANCER SCREENING DEVICE MARKET SIZE, BY MRI (MAGNETIC RESONANCE IMAGING), 2018-2030 (USD MILLION)
TABLE 171. MEXICO BREAST CANCER SCREENING DEVICE MARKET SIZE, BY COMPUTER-AIDED DETECTION, 2018-2030 (USD MILLION)
TABLE 172. MEXICO BREAST CANCER SCREENING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 173. MEXICO BREAST CANCER SCREENING DEVICE MARKET SIZE, BY DIGITAL TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 174. MEXICO BREAST CANCER SCREENING DEVICE MARKET SIZE, BY ADVANCED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 175. MEXICO BREAST CANCER SCREENING DEVICE MARKET SIZE, BY END-USER APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. MEXICO BREAST CANCER SCREENING DEVICE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 177. MEXICO BREAST CANCER SCREENING DEVICE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 178. MEXICO BREAST CANCER SCREENING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 179. MEXICO BREAST CANCER SCREENING DEVICE MARKET SIZE, BY SCREENING METHODS, 2018-2030 (USD MILLION)
TABLE 180. MEXICO BREAST CANCER SCREENING DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 181. MEXICO BREAST CANCER SCREENING DEVICE MARKET SIZE, BY 65 AND ABOVE, 2018-2030 (USD MILLION)
TABLE 182. MEXICO BREAST CANCER SCREENING DEVICE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 183. MEXICO BREAST CANCER SCREENING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 184. MEXICO BREAST CANCER SCREENING DEVICE MARKET SIZE, BY TELEHEALTH, 2018-2030 (USD MILLION)
TABLE 185. MEXICO BREAST CANCER SCREENING DEVICE MARKET SIZE, BY INNOVATIVE FEATURES, 2018-2030 (USD MILLION)
TABLE 186. MEXICO BREAST CANCER SCREENING DEVICE MARKET SIZE, BY CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 187. UNITED STATES BREAST CANCER SCREENING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 188. UNITED STATES BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 189. UNITED STATES BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 190. UNITED STATES BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST MRI, 2018-2030 (USD MILLION)
TABLE 191. UNITED STATES BREAST CANCER SCREENING DEVICE MARKET SIZE, BY MRI (MAGNETIC RESONANCE IMAGING), 2018-2030 (USD MILLION)
TABLE 192. UNITED STATES BREAST CANCER SCREENING DEVICE MARKET SIZE, BY COMPUTER-AIDED DETECTION, 2018-2030 (USD MILLION)
TABLE 193. UNITED STATES BREAST CANCER SCREENING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 194. UNITED STATES BREAST CANCER SCREENING DEVICE MARKET SIZE, BY DIGITAL TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 195. UNITED STATES BREAST CANCER SCREENING DEVICE MARKET SIZE, BY ADVANCED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 196. UNITED STATES BREAST CANCER SCREENING DEVICE MARKET SIZE, BY END-USER APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. UNITED STATES BREAST CANCER SCREENING DEVICE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 198. UNITED STATES BREAST CANCER SCREENING DEVICE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 199. UNITED STATES BREAST CANCER SCREENING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 200. UNITED STATES BREAST CANCER SCREENING DEVICE MARKET SIZE, BY SCREENING METHODS, 2018-2030 (USD MILLION)
TABLE 201. UNITED STATES BREAST CANCER SCREENING DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 202. UNITED STATES BREAST CANCER SCREENING DEVICE MARKET SIZE, BY 65 AND ABOVE, 2018-2030 (USD MILLION)
TABLE 203. UNITED STATES BREAST CANCER SCREENING DEVICE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 204. UNITED STATES BREAST CANCER SCREENING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 205. UNITED STATES BREAST CANCER SCREENING DEVICE MARKET SIZE, BY TELEHEALTH, 2018-2030 (USD MILLION)
TABLE 206. UNITED STATES BREAST CANCER SCREENING DEVICE MARKET SIZE, BY INNOVATIVE FEATURES, 2018-2030 (USD MILLION)
TABLE 207. UNITED STATES BREAST CANCER SCREENING DEVICE MARKET SIZE, BY CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 208. UNITED STATES BREAST CANCER SCREENING DEVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 209. ASIA-PACIFIC BREAST CANCER SCREENING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 210. ASIA-PACIFIC BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 211. ASIA-PACIFIC BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 212. ASIA-PACIFIC BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST MRI, 2018-2030 (USD MILLION)
TABLE 213. ASIA-PACIFIC BREAST CANCER SCREENING DEVICE MARKET SIZE, BY MRI (MAGNETIC RESONANCE IMAGING), 2018-2030 (USD MILLION)
TABLE 214. ASIA-PACIFIC BREAST CANCER SCREENING DEVICE MARKET SIZE, BY COMPUTER-AIDED DETECTION, 2018-2030 (USD MILLION)
TABLE 215. ASIA-PACIFIC BREAST CANCER SCREENING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 216. ASIA-PACIFIC BREAST CANCER SCREENING DEVICE MARKET SIZE, BY DIGITAL TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 217. ASIA-PACIFIC BREAST CANCER SCREENING DEVICE MARKET SIZE, BY ADVANCED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 218. ASIA-PACIFIC BREAST CANCER SCREENING DEVICE MARKET SIZE, BY END-USER APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. ASIA-PACIFIC BREAST CANCER SCREENING DEVICE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 220. ASIA-PACIFIC BREAST CANCER SCREENING DEVICE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 221. ASIA-PACIFIC BREAST CANCER SCREENING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 222. ASIA-PACIFIC BREAST CANCER SCREENING DEVICE MARKET SIZE, BY SCREENING METHODS, 2018-2030 (USD MILLION)
TABLE 223. ASIA-PACIFIC BREAST CANCER SCREENING DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 224. ASIA-PACIFIC BREAST CANCER SCREENING DEVICE MARKET SIZE, BY 65 AND ABOVE, 2018-2030 (USD MILLION)
TABLE 225. ASIA-PACIFIC BREAST CANCER SCREENING DEVICE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 226. ASIA-PACIFIC BREAST CANCER SCREENING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 227. ASIA-PACIFIC BREAST CANCER SCREENING DEVICE MARKET SIZE, BY TELEHEALTH, 2018-2030 (USD MILLION)
TABLE 228. ASIA-PACIFIC BREAST CANCER SCREENING DEVICE MARKET SIZE, BY INNOVATIVE FEATURES, 2018-2030 (USD MILLION)
TABLE 229. ASIA-PACIFIC BREAST CANCER SCREENING DEVICE MARKET SIZE, BY CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 230. ASIA-PACIFIC BREAST CANCER SCREENING DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 231. AUSTRALIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 232. AUSTRALIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 233. AUSTRALIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 234. AUSTRALIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST MRI, 2018-2030 (USD MILLION)
TABLE 235. AUSTRALIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY MRI (MAGNETIC RESONANCE IMAGING), 2018-2030 (USD MILLION)
TABLE 236. AUSTRALIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY COMPUTER-AIDED DETECTION, 2018-2030 (USD MILLION)
TABLE 237. AUSTRALIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 238. AUSTRALIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY DIGITAL TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 239. AUSTRALIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY ADVANCED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 240. AUSTRALIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY END-USER APPLICATION, 2018-2030 (USD MILLION)
TABLE 241. AUSTRALIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 242. AUSTRALIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 243. AUSTRALIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 244. AUSTRALIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY SCREENING METHODS, 2018-2030 (USD MILLION)
TABLE 245. AUSTRALIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 246. AUSTRALIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY 65 AND ABOVE, 2018-2030 (USD MILLION)
TABLE 247. AUSTRALIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 248. AUSTRALIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 249. AUSTRALIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY TELEHEALTH, 2018-2030 (USD MILLION)
TABLE 250. AUSTRALIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY INNOVATIVE FEATURES, 2018-2030 (USD MILLION)
TABLE 251. AUSTRALIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 252. CHINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 253. CHINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 254. CHINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 255. CHINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST MRI, 2018-2030 (USD MILLION)
TABLE 256. CHINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY MRI (MAGNETIC RESONANCE IMAGING), 2018-2030 (USD MILLION)
TABLE 257. CHINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY COMPUTER-AIDED DETECTION, 2018-2030 (USD MILLION)
TABLE 258. CHINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 259. CHINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY DIGITAL TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 260. CHINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY ADVANCED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 261. CHINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY END-USER APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. CHINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 263. CHINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 264. CHINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 265. CHINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY SCREENING METHODS, 2018-2030 (USD MILLION)
TABLE 266. CHINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 267. CHINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY 65 AND ABOVE, 2018-2030 (USD MILLION)
TABLE 268. CHINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 269. CHINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 270. CHINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY TELEHEALTH, 2018-2030 (USD MILLION)
TABLE 271. CHINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY INNOVATIVE FEATURES, 2018-2030 (USD MILLION)
TABLE 272. CHINA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 273. INDIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 274. INDIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 275. INDIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 276. INDIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST MRI, 2018-2030 (USD MILLION)
TABLE 277. INDIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY MRI (MAGNETIC RESONANCE IMAGING), 2018-2030 (USD MILLION)
TABLE 278. INDIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY COMPUTER-AIDED DETECTION, 2018-2030 (USD MILLION)
TABLE 279. INDIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 280. INDIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY DIGITAL TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 281. INDIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY ADVANCED TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 282. INDIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY END-USER APPLICATION, 2018-2030 (USD MILLION)
TABLE 283. INDIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 284. INDIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 285. INDIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 286. INDIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY SCREENING METHODS, 2018-2030 (USD MILLION)
TABLE 287. INDIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 288. INDIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY 65 AND ABOVE, 2018-2030 (USD MILLION)
TABLE 289. INDIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 290. INDIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 291. INDIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY TELEHEALTH, 2018-2030 (USD MILLION)
TABLE 292. INDIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY INNOVATIVE FEATURES, 2018-2030 (USD MILLION)
TABLE 293. INDIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 294. INDONESIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 295. INDONESIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 296. INDONESIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST IMAGING DEVICES, 2018-2030 (USD MILLION)
TABLE 297. INDONESIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY BREAST MRI, 2018-2030 (USD MILLION)
TABLE 298. INDONESIA BREAST CANCER SCREENING DEVICE MARKET SIZE, BY MRI (MAGNETIC RESONANC
Companies Mentioned
- Agilent Technologies, Inc.
- Canon Medical Systems Corporation
- CureMetrix
- Endomag
- FUJIFILM Holdings Corporation
- GE HealthCare
- Hologic, Inc.
- iCAD, Inc.
- Konica Minolta, Inc.
- Philips Healthcare
- Planmed Oy
- QView Medical, Inc.
- ScreenPoint Medical
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
- Toshiba Medical Systems Corporation
- Volpara Health Technologies
Methodology
LOADING...
